Students are invited to a lunchtime discussion with Jessica Flanigan, Assistant Professor of Leadership Studies and Philosophy, Politics, Economics and Law at the University of Richmond.

Professor Flanigan will argue that truthful off-label pharmaceutical marketing and direct-to-consumer advertising should be permitted. The current standards for regulating commercial speech cannot justify regulations limiting truthful off-label marketing of pharmaceuticals. The moral considerations that justify free-speech protections also justify legal protections for off-label and direct-to-consumer pharmaceutical marketing.
RSVP to Dr. Mark Cherry at markc [at]